Skip to main content

Evoke Pharma Inc

EVOKDelisted Dec 17, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001403708

Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
15
Q3 2025, +5 vs. previous quarter
13F value
$2.94M
Reported value at the end of Q3 2025
Superinvestors holding
0
At the end of Q3 2025

From SEC filings, in USD.

Revenue, FY2024
$10.2M
+97.8% year over year
Net income, FY2024
-$5.35M
No comparable prior period
Free cash flow, FY2024
–
No comparable prior period
Revenue, Q3 FY2025
$4.28M
+61.4% year over year

Revenue flow, FY2024

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2024: $5.35M (52.2% of revenue).

Short interest

See short data

From FINRA, settlement date Dec 15, 2025.

Short interest
10.9K
Shares sold short
Change
+3.92K
+56.2% vs. previous
Days to cover
1.00
At average daily volume

Superinvestors holding EVOK, Q3 2025

Go to the superinvestors tab

No superinvestor reported holding EVOK at the end of Q3 2025.

Latest insider trades

See all insider trades

Open-market purchases and sales by Evoke Pharma Inc insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 7, 2025 (view filing)Nov 61 dayKlein Roger M.10% OwnerSSale−9.00K$10.66−$95.9K−6.7%125.0K after2 lots
Jan 30, 2025 (view filing)6:39 PM ETJan 282 daysNantahala Capital Management, LLC and 2 others10% OwnerSSale−41$4.39−$179.870.0%148.2K after

Top 10 13F holders, Q3 2025

See all 15 holders

The largest institutional positions in Evoke Pharma Inc at the end of Q3 2025; share changes are against Q2 2025.

Institutions holding EVOK in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Morgan Stanley159,358$792.0K0.00%+159,294+248,896.9%Added
Nantahala Capital Management, LLC148,153$736.3K0.05%00.0%Unchanged
Bleichroeder LP146,395$727.6K0.14%+77,645+112.9%Added
National Wealth Management Group, LLC80,130$398.2K0.15%+80,130New
DRW Securities, LLC23,742$118.0K0.01%+23,742New
Vanguard Group Inc18,759$93.2K0.00%+18,759New
Two Sigma Securities, LLC10,437$51.9K0.01%+10,437New
Advisor Group Holdings, Inc.3,010$16.4K0.00%+3,010New
Northwestern Mutual Wealth Management Co272$1.35K0.00%+272New
Royal Bank of Canada190$1.00K0.00%+190New

Holders of 5% or more of EVOK

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Evoke Pharma Inc.

Largest holders of EVOK from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Klein Roger M.13D10.50%163.0K sharesNewNov 12, 20251 filingNov 12, 2025SEC
Bleichroeder LP13G/A9.99%158.1K shares0.00 ppfrom 9.99%Mar 11, 20243 filingsMar 24, 2025SEC